$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
NEW YORK--(BUSINESS WIRE)---- $IOVA #Attorney--Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and c
Class Action Lawsuit Filed: Iovance Biotherapeutics, Inc. (IOVA) - Join by July 14, 2025 - Contact Levi & Korsinsky
07:15am, Tuesday, 20'th May 2025
NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
NEW YORK CITY, NY / ACCESS Newswire / May 20, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Iovance
NEW YORK , May 20, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ: IOVA) of a class action securities lawsuit. CLA
Investors Urged to Contact Levi & Korsinsky for Information Before July 14, 2025 - Iovance Biotherapeutics, Inc. (IOVA)
11:15pm, Monday, 19'th May 2025
NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federa
NEW YORK CITY, NY AND NEW ORLEANS, LA / ACCESS Newswire / May 19, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors wi
Securities Class Action Lawsuit Filed Against Iovance Biotherapeutics, Inc. (IOVA) - Levi & Korsinsky Represents Shareholders
07:00pm, Monday, 19'th May 2025
NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Urged to Join Class Action Before July 14, 2025 - Contact Levi & Korsinsky
05:30pm, Monday, 19'th May 2025
NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certa
Recover Investment Losses: Levi & Korsinsky Files Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
04:30pm, Monday, 19'th May 2025
NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
NEW YORK , May 19, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed a
Class Action Filed Against Iovance Biotherapeutics, Inc. (IOVA) Seeking Recovery for Investors - Contact The Gross Law Firm
03:01pm, Monday, 19'th May 2025
NEW YORK , May 19, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA). Shareholders who purchased shares of IOVA durin
July 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against IOVA
01:31pm, Monday, 19'th May 2025
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ: IOVA) of a class action securities lawsuit.
Levi & Korsinsky Urges Iovance (IOVA) Shareholders to Act Before Lead Plaintiff Deadline July 14, 2025
01:15pm, Monday, 19'th May 2025
NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
IOVA LAWSUIT ALERT: Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. Investors - Lead Plaintiff Deadline July 14, 2025
12:45pm, Monday, 19'th May 2025
NEW YORK, NY / ACCESS Newswire / May 19, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
Sign In
Buy IOVA